Hi Mike thanks for your feedback
"No one bought in 5 years ago expecting us to still be at pre-scoping study stage in 2023 and $200 million spent.I know I certainly did not."
Perhaps you may be able to explain to me what the strategic objectives were for the company when they were trying to acquire Cortadera. This fits into your time line of 5 years ago.
- Forums
- ASX - By Stock
- HCH
- $?Bill in a ? Life mine
$?Bill in a ? Life mine, page-20755
Featured News
Add HCH (ASX) to my watchlist
(20min delay)
|
|||||
Last
80.0¢ |
Change
-0.005(0.62%) |
Mkt cap ! $121.1M |
Open | High | Low | Value | Volume |
81.0¢ | 81.5¢ | 78.0¢ | $95.36K | 119.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6410 | 78.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
80.0¢ | 4696 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6410 | 0.780 |
4 | 12197 | 0.770 |
1 | 1307 | 0.765 |
2 | 9100 | 0.760 |
4 | 14832 | 0.750 |
Price($) | Vol. | No. |
---|---|---|
0.800 | 4696 | 1 |
0.805 | 1000 | 1 |
0.830 | 1000 | 1 |
0.835 | 1432 | 2 |
0.840 | 65042 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
HCH (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online